Artwork

Content provided by Healthegy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healthegy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode: 167 - M&A, IPO or SPAC: CEOs Share Exit Strategies and Lessons Learned Along the Way

1:01:32
 
Share
 

Manage episode 326025762 series 2285732
Content provided by Healthegy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healthegy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Geoff Pardo and three successful medtech CEOs who exited their companies through a different pathway— M&A, IPO, and SPAC—discuss the pros and cons of each. While market volatility is a given, Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical; Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth; and Leslie Trigg, CEO, Outset Medical agreed that successful CEOs keep their focus on delivering returns for their investors—whether private or public. If your company is solving a really important problem and is creating value for patients, you’ll ultimately succeed, Shook said. From there, Trigg pointed out, exit vehicles are simply different modes of transportation to the same place.
GUESTS:
Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical
Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth
Leslie Trigg, CEO, Outset Medical, Inc.

HOST:
Geoff Pardo, General Partner, Gilde Healthcare; Host, Medtech Talk podcast

LINKS:
Cambridge Healthtech Institute
Medtech Talk
Gilde Healthcare
OrangeTwist
Outset Medical

  continue reading

188 episodes

Artwork
iconShare
 
Manage episode 326025762 series 2285732
Content provided by Healthegy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healthegy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Geoff Pardo and three successful medtech CEOs who exited their companies through a different pathway— M&A, IPO, and SPAC—discuss the pros and cons of each. While market volatility is a given, Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical; Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth; and Leslie Trigg, CEO, Outset Medical agreed that successful CEOs keep their focus on delivering returns for their investors—whether private or public. If your company is solving a really important problem and is creating value for patients, you’ll ultimately succeed, Shook said. From there, Trigg pointed out, exit vehicles are simply different modes of transportation to the same place.
GUESTS:
Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical
Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth
Leslie Trigg, CEO, Outset Medical, Inc.

HOST:
Geoff Pardo, General Partner, Gilde Healthcare; Host, Medtech Talk podcast

LINKS:
Cambridge Healthtech Institute
Medtech Talk
Gilde Healthcare
OrangeTwist
Outset Medical

  continue reading

188 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide